-
1
-
-
67649841563
-
Autosomal dominant polycystic kidney disease: The last 3 years
-
Torres VE, Harris PC. Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int 2009; 76: 149-168.
-
(2009)
Kidney Int
, vol.76
, pp. 149-168
-
-
Torres, V.E.1
Harris, P.C.2
-
2
-
-
34948847732
-
Surgical management of polycystic liver disease
-
Russell RT, Pinson CW. Surgical management of polycystic liver disease. World J Gastroenterol 2007; 13: 5052-5059. (Pubitemid 47527340)
-
(2007)
World Journal of Gastroenterology
, vol.13
, Issue.38
, pp. 5052-5059
-
-
Russell, R.T.1
Pinson, C.W.2
-
3
-
-
1842427829
-
Abnormal hepatocystin caused by truncating PRKCSH mutations leads to autosomal dominant polycystic liver disease
-
Drenth JP, Tahvanainen E, te Morsche RH, Tahvanainen P, Kaariainen H, Hockerstedt K et al. Abnormal hepatocystin caused by truncating PRKCSH mutations leads to autosomal dominant polycystic liver disease. Hepatology 2004; 39: 924-931.
-
(2004)
Hepatology
, vol.39
, pp. 924-931
-
-
Drenth, J.P.1
Tahvanainen, E.2
Te Morsche, R.H.3
Tahvanainen, P.4
Kaariainen, H.5
Hockerstedt, K.6
-
4
-
-
2642528473
-
Mutations in SEC63 cause autosomal dominant polycystic liver disease
-
DOI 10.1038/ng1357
-
Davila S, Furu L, Gharavi AG, Tian X, Onoe T, Qian Q et al. Mutations in SEC63 cause autosomal dominant polycystic liver disease. Nat Genet 2004; 36: 575-577. (Pubitemid 38715981)
-
(2004)
Nature Genetics
, vol.36
, Issue.6
, pp. 575-577
-
-
Davila, S.1
Furu, L.2
Gharavi, A.G.3
Tian, X.4
Onoe, T.5
Qian, Q.6
Li, A.7
Cai, Y.8
Kamath, P.S.9
King, B.F.10
Azurmendi, P.J.11
Tahvanainen, P.12
Kaariainen, H.13
Hockerstedt, K.14
Devuyst, O.15
Pirson, Y.16
Martin, R.S.17
Lifton, R.P.18
Tahvanainen, E.19
Torres, V.E.20
Somlo, S.21
more..
-
5
-
-
54349111664
-
Cystic tumors of the liver: A practical approach
-
Del Poggio P, Buonocore M. Cystic tumors of the liver: a practical approach. World J Gastroenterol 2008; 14: 3616-3620.
-
(2008)
World J Gastroenterol
, vol.14
, pp. 3616-3620
-
-
Del Poggio, P.1
Buonocore, M.2
-
6
-
-
46449106752
-
Aspiration-sclerotherapy results in effective control of liver volume in patients with liver cysts
-
van Keimpema L, de Koning DB, Strijk SP, Drenth JP. Aspiration- sclerotherapy results in effective control of liver volume in patients with liver cysts. Dig Dis Sci 2008; 53: 2251-2257.
-
(2008)
Dig Dis Sci
, vol.53
, pp. 2251-2257
-
-
Van Keimpema, L.1
De Koning, D.B.2
Strijk, S.P.3
Drenth, J.P.4
-
7
-
-
38949192509
-
Laparoscopic fenestration of liver cysts in polycystic liver disease results in a median volume reduction of 12•5%
-
van Keimpema L, Ruurda JP, Ernst MF, van Geffen HJ, Drenth JP. Laparoscopic fenestration of liver cysts in polycystic liver disease results in a median volume reduction of 12•5%. J Gastrointest Surg 2008; 12: 477-482.
-
(2008)
J Gastrointest Surg
, vol.12
, pp. 477-482
-
-
Van Keimpema, L.1
Ruurda, J.P.2
Ernst, M.F.3
Van Geffen, H.J.4
Drenth, J.P.5
-
8
-
-
13444249601
-
Laparoscopic fenestration for the treatment of patients with severe adult polycystic liver disease
-
DOI 10.1016/j.amjsurg.2004.03.011
-
Konstadoulakis MM, Gomatos IP, Albanopoulos K, Alexakis N, Leandros E. Laparoscopic fenestration for the treatment of patients with severe adult polycystic liver disease. Am J Surg 2005; 189: 71-75. (Pubitemid 40215510)
-
(2005)
American Journal of Surgery
, vol.189
, Issue.1
, pp. 71-75
-
-
Konstadoulakis, M.M.1
Gomatos, I.P.2
Albanopoulos, K.3
Alexakis, N.4
Leandros, E.5
-
9
-
-
33947315462
-
Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3′,5′-cyclic monophosphate
-
Masyuk TV, Masyuk AI, Torres VE, Harris PC, Larusso NF. Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3′,5′-cyclic monophosphate. Gastroenterology 2007; 132: 1104-1116.
-
(2007)
Gastroenterology
, vol.132
, pp. 1104-1116
-
-
Masyuk, T.V.1
Masyuk, A.I.2
Torres, V.E.3
Harris, P.C.4
Larusso, N.F.5
-
10
-
-
50249105373
-
Somatostatin analogues reduce liver volume in polycystic liver disease
-
van Keimpema L, de Man RA, Drenth JP. Somatostatin analogues reduce liver volume in polycystic liver disease. Gut 2008; 57: 1338-1339.
-
(2008)
Gut
, vol.57
, pp. 1338-1339
-
-
Van Keimpema, L.1
De Man, R.A.2
Drenth, J.P.3
|